FR3797M - New pharmaceutical preparation for the treatment of diabetes mellitus. - Google Patents

New pharmaceutical preparation for the treatment of diabetes mellitus.

Info

Publication number
FR3797M
FR3797M FR993173A FR993173A FR3797M FR 3797 M FR3797 M FR 3797M FR 993173 A FR993173 A FR 993173A FR 993173 A FR993173 A FR 993173A FR 3797 M FR3797 M FR 3797M
Authority
FR
France
Prior art keywords
treatment
diabetes mellitus
pharmaceutical preparation
new pharmaceutical
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR993173A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of FR3797M publication Critical patent/FR3797M/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/42—Benzene-sulfonamido pyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR993173A 1963-11-05 1964-10-29 New pharmaceutical preparation for the treatment of diabetes mellitus. Expired FR3797M (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1359863 1963-11-05
CH1210364 1964-09-17

Publications (1)

Publication Number Publication Date
FR3797M true FR3797M (en) 1965-12-27

Family

ID=25709624

Family Applications (2)

Application Number Title Priority Date Filing Date
FR993173A Expired FR3797M (en) 1963-11-05 1964-10-29 New pharmaceutical preparation for the treatment of diabetes mellitus.
FR993172A Expired FR4034M (en) 1963-11-05 1965-10-29

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR993172A Expired FR4034M (en) 1963-11-05 1965-10-29

Country Status (5)

Country Link
BE (1) BE655242A (en)
DE (1) DE1467832A1 (en)
FR (2) FR3797M (en)
GB (1) GB1054278A (en)
NL (1) NL6412822A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3503609A1 (en) * 1985-02-02 1986-08-07 Bayer Ag, 5090 Leverkusen 5-SULPHONAMIDO-1-ARYL-PYRAZOLE
WO2013046041A1 (en) * 2011-09-30 2013-04-04 Synovo Gmbh Pyridinylpyrazoles for use as kinase modulators for the treatment of cancer
RU2664705C2 (en) * 2013-01-17 2018-08-21 Ф. Хоффманн-Ля Рош Аг Oxytocine receptor agonists for the central nervous system diseases treatment
RU2579515C1 (en) * 2014-12-29 2016-04-10 Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный технологический университет" (СибГТУ) Alkoxymethyl-substituted 1h-4-aminopyrazoles

Also Published As

Publication number Publication date
GB1054278A (en) 1967-01-11
NL6412822A (en) 1965-05-06
BE655242A (en) 1965-05-04
DE1467832A1 (en) 1968-11-28
FR4034M (en) 1966-03-28

Similar Documents

Publication Publication Date Title
FR3384M (en) New composition for pharmaceutical aerosols.
CH443268A (en) Process for the preparation of new pseudo-ionones
FR3010M (en) New drugs derived from benzene for the treatment of heart disease.
FR3797M (en) New pharmaceutical preparation for the treatment of diabetes mellitus.
FR2489M (en) Drug for the treatment of amoebic dysentery.
OA00939A (en) Process for the preparation of amino-isoxazoles.
FR2193M (en) New drug for the treatment of infectious diseases.
FR1463838A (en) Process for the preparation of new benzenesulfonylureas
FR3066M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
BE812974A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ULCERS
FR1338926A (en) Furnace for the treatment of strips
FR2929M (en) Pharmaceutical composition for the treatment of arthritic and rheumatic conditions.
FR2817M (en) Combinations of drugs for the treatment of mental disorders.
FR2346M (en) Drug for the treatment of colopathies.
FR2684M (en) Pharmaceutical composition for the local treatment of rheumatic pain.
BE650350A (en) COMPOSITION FOR THE TREATMENT OF DROPS
BE772424A (en) DERMOPHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SEBORREHEIC AFFECTIONS
FR1424566A (en) New tablets for the preparation of photographic processing baths
FR2965M (en) Therapeutic preparation for the treatment of anginal syndromes.
FR1911M (en) New drug for the treatment of disorders of the circulatory system.
FR2536M (en) New composition for the treatment of bilharzia.
BE792933A (en) MEDICINE FOR THE TREATMENT OF HYPERCINETIC SYNDROME
FR3744M (en) Drugs for the treatment of psychiatric conditions.
FR3569M (en) Therapeutic composition for the correction of intestinal dysmicrobism.
FR2323M (en) New drug, in particular for the treatment of follicle-stimulating hyperactivity.